Piperacillin Sodium

哌拉西林钠

Report date: 2022/05/16 12:12:24
NME

Base Information

Drug NamePiperacillin Sodium
Drug Alias Name哌拉西林piperacilinapiperacillinumPipracilCL-227193 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1981/12/29
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesHunan Kelun Pharmaceutical Co Ltd
Inactive CompaniesWyeth Pharmaceuticals Inc
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01CA12
Related LinksWikipediaDrugBankKEGG